Affymetrix and Vita Genomics Collaborate to Develop Microarray-based IVD Products.

Business Wire › December 26, 2005

Linked as:

Extract

Affymetrix and Vita Genomics Collaborate to Develop Microarray-based IVD Products.

SANTA CLARA, Calif. & TAIPEI, Taiwan -- Affymetrix Inc. (Nasdaq: AFFX) and Vita Genomics announced today that Affymetrix has granted Vita Genomics and its fully owned subsidiary, Shanghai GeneCore BioTechnologies, non-exclusive access to Affymetrix microarray technology to develop and market in-vitro diagnostic (IVD) tests for Alpha Interferon Treatment response in patients with HB...

See the full content of this document